Amgen submits BLA for Infliximab biosimilar ABP 710 to FDA

pharmanewsdaily- December 18, 2018 0

Amgen Inc. has officially submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ABP 710, a biosimilar candidate to ... Read More

Novartis’ Sandoz gains EC approval for biosimilar Hyrimoz across multiple therapeutic areas

pharmanewsdaily- July 29, 2018 0

In a significant advancement for biopharmaceuticals, Novartis' division Sandoz has secured approval from the European Commission (EC) for Hyrimoz (adalimumab), a biosimilar to AbbVie’s Humira. ... Read More

12322 / 22 Posts